↓ Skip to main content

Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment

Overview of attention for article published in BMC Infectious Diseases, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment
Published in
BMC Infectious Diseases, February 2013
DOI 10.1186/1471-2334-13-85
Pubmed ID
Authors

Yves Jackson, Eric Chatelain, Anne Mauris, Marylise Holst, Qianqian Miao, Francois Chappuis, Momar Ndao

Abstract

With declining vectorial transmission, Chagas disease predominantly affects adults nowadays. The efficacy of nifurtimox in the chronic phase in adult patients is poorly known, particularly in regions where there is no risk of reinfection. Recommendations for treatment outcome assessment rely on serological follow-up. We evaluated the serological and parasitological response to nifurtimox in a cohort of adult patients three years post-treatment in Switzerland.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
Germany 1 2%
Colombia 1 2%
Chile 1 2%
Argentina 1 2%
Unknown 55 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 23%
Student > Ph. D. Student 12 20%
Student > Master 7 11%
Student > Bachelor 4 7%
Student > Postgraduate 3 5%
Other 9 15%
Unknown 12 20%
Readers by discipline Count As %
Medicine and Dentistry 18 30%
Agricultural and Biological Sciences 8 13%
Biochemistry, Genetics and Molecular Biology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Social Sciences 3 5%
Other 6 10%
Unknown 18 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2022.
All research outputs
#3,585,456
of 22,908,162 outputs
Outputs from BMC Infectious Diseases
#1,134
of 7,692 outputs
Outputs of similar age
#39,377
of 288,404 outputs
Outputs of similar age from BMC Infectious Diseases
#19
of 157 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,692 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,404 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.